AU2002302509A1 - Arylsulfonamides as antiviral agents - Google Patents

Arylsulfonamides as antiviral agents

Info

Publication number
AU2002302509A1
AU2002302509A1 AU2002302509A AU2002302509A AU2002302509A1 AU 2002302509 A1 AU2002302509 A1 AU 2002302509A1 AU 2002302509 A AU2002302509 A AU 2002302509A AU 2002302509 A AU2002302509 A AU 2002302509A AU 2002302509 A1 AU2002302509 A1 AU 2002302509A1
Authority
AU
Australia
Prior art keywords
arylsulfonamides
antiviral agents
antiviral
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002302509A
Inventor
Wolfgang Bender
Peter Eckenberg
Sabine Hallenberger
Kerstin Henninger
Jorg Keldenich
Armin Kern
Siegfried Raddatz
Martin Radtke
Jurgen Reefschlager
Gunter Schmidt
Tobias Wunberg
Holger Zimmermann
Franz Zumpe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of AU2002302509A1 publication Critical patent/AU2002302509A1/en
Abandoned legal-status Critical Current

Links

AU2002302509A 2001-04-19 2002-04-08 Arylsulfonamides as antiviral agents Abandoned AU2002302509A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10119137.5 2001-04-19
DE10148598.0 2001-10-02

Publications (1)

Publication Number Publication Date
AU2002302509A1 true AU2002302509A1 (en) 2002-11-05

Family

ID=

Similar Documents

Publication Publication Date Title
AU2002221344A1 (en) Antiviral agents
HK1066218A1 (en) Qunazoline derivatives as antitumor agents
AU2002360508A1 (en) Substituted hydroxyethylamines
EG26021A (en) Benzoyl sulfonamide derivatives as antitumor agents
AU2002315122A1 (en) Self-guyed structures
AU2002360487A1 (en) Acyclovir-peptide analogs
AU2002350244A1 (en) Pyridoquinoxaline antivirals
AU2002251024A1 (en) Substituted fluoroalcoxyphenylsulfonylurea
AU2002352882A1 (en) Pyridoquinoxaline antivirals
AU2002343312A1 (en) Two fixed-beams tx-diversity
AU2002321215A1 (en) Substituted 4-aminocyclohexanols
AU2002256497A1 (en) Sulfonamides
AU2003269950A1 (en) Heteroaryl-ethanolamine derivatives as antiviral agents
AU2003304151A1 (en) Heteroaryl-ethanolamine derivatives as antiviral agents
AU2002302509A1 (en) Arylsulfonamides as antiviral agents
AU2003265385A1 (en) Aryl-ethanolamine derivatives as antiviral agents
AU2001295326A1 (en) Chloramines as antiviral agents
CA97086S (en) Sprayer
AU2003258612A1 (en) Pyrimidones as antiviral agents
AU2002243848A1 (en) Substituted quinolinecarboxamides as antiviral agents
AUPR775601A0 (en) Antiviral agents
AUPR520201A0 (en) Antiviral compounds
AU2002320703A1 (en) Antiviral agent
AU2002951615A0 (en) Antiviral agents
AU2002344495A1 (en) Anticaner agents